Syndax Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.65 |
Market Cap |
$252.26 M |
Shares Outstanding |
27.1 M |
Public Float |
19.77 M |
Address |
35 Gatehouse Drive Waltham Massachusetts 02451 United States |
Employees | - |
Website | http://www.syndax.com |
Updated | 07/08/2019 |
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. |